Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)
This study has been completed.
Study NCT01122667   Information provided by Merck

First Received on May 11, 2010.   Last Updated on July 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dyslipidemia
Additional conditions recognized in this trial
Dyslipidemias
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Lipid Metabolism Disorders
Metabolic Diseases
Urologic Diseases
Interventions listed in this trial
anacetrapib
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services